Agenda-setting intelligence, analysis and advice for the global fashion community.

Novo Nordisk’s ‘Super Ozempic’ Trial Disappoints Again

The drugmaker’s shares dropped after releasing weaker-than-expected trial results for next generation drug CagriSema, which failed to outperform Eli Lilly’s Mounjaro.

Famed for speedy weight loss, Ozempic is having far-reaching consequences. — The data comes after Novo revealed results from a separate trial of CagriSema in December that also disappointed the market. (Shutterstock)

Reuters

10 March 2025

BoF PROFESSIONAL

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares and stoking worries that rival Eli Lilly may be gaining an edge over the company in the weight-loss drugs market.

Please sign in to ensure you can read our agenda-setting intelligence, analysis and advice. Or get in touch at support@businessoffashion.com if you experience difficulties.

Wellness Wants in on the Ozempic Economy

From supplements to workout plans, the term GLP-1, the hormone associated with Ozempic, is popping up on a widespread range of new products as wellness brands join in on the weight loss drug boom.

Ozempic ‘Very Likely’ to Face Drug Price Negotiations, Novo Says

The US Centers for Medicare and Medicaid Services will announce the next set of 15 retail prescription drugs selected for negotiation by February 1, 2025.

The Start-Ups Turning Ozempic Into the Next Botox

From medspas to telemedicine, weight loss drugs are becoming adopted for mainstream cosmetic use.

In This Article

Topics

Beauty:Wellness

Can Mikayla Nogueira Sell Fragrance, Too?

The beauty influencer is hoping her 20 million-strong following can cut through the category’s oversaturation with Only Sunshine, a tropical scent launched with indie brand Snif.

Ulta Beauty Joins TikTok Shop

Ulta Beauty becomes the first US specialty beauty retailer to launch on TikTok Shop, making the case for partnership rather than competition with the platform’s beauty e-commerce business.

For Beauty Brands, What’s a Department Store Worth?

In Full Coverage, Priya Rao looks at the world’s buzziest luxury department stores in Paris.

For Niche Fragrance Makers, Time Is On Their Side

For centuries, perfumers have aged fragrances to get their best scent expressions. More recently, time is becoming a crucial marketing tool.

Underdays and Foundrae Are Hiring on BoF Careers

Check out this week’s new partner and job openings on BoF Careers, the global marketplace for fashion and beauty talent.

Can Lake Translate Success in Sleepwear Outside the Bedroom?

The Savannah, Ga.-based pajama brand has developed a devoted following for its super-soft pyjamas. With their first daywear collection, they’re hoping that loyalty will apply in a much more competitive category

Who Won Fashion’s Red Carpet Season of Change

Sunday night’s Oscars concluded an awards season that fashion’s biggest labels used to show off their new creative game. BoF breaks down what we learned about brands’ celebrity strategies.

Trump Signs Order to Combat Fraudulent ‘Made in America’ Labels, White House Says

The executive order directs ⁠the FTC chairman to prioritise enforcement of existing laws against sellers and manufacturers who falsely claim products are made in America.

The Business of Fashion

Agenda-setting intelligence, analysis and advice for the global fashion community.

CONNECT WITH US ON

News & Analysis

Topics

More

Careers

Community

Subscribe

About Us